- November 28, 2023
New Advanced Diagnostic Tests Lab to Perform, Interpret Clinical-Grade Molecular Testing of Biomarkers
- January 10, 2023
Class of 1961 Cancer Research Awards Announced
- September 22, 2022Source: UNIVISION
De Qué Trata la Inmunoterapia, un Tratamiento Que ha Mostrado Grandes Avances en la Lucha Contra el Cáncer
- September 06, 2022Source: PR Newswire
Cancer Research Institute To Host Second-Annual Spanish-Language Virtual Immunotherapy Patient Summit, Moderated By Ana Patricia Gámez, To Connect The U.S. Hispanic Cancer Community With Information That Can Save Lives
Welcome to the Schalper Lab
My research is focused on understanding the immunobiology of human solid tumors and develop molecular biomarkers for prediction of response or resistance to therapies. In particular, my group has been actively evaluating the role of specific tumor antigens and immune evasion pathways used by human lung malignancies including immune co-inhibitory/stimulatory ligands and receptors, tolerogenic enzymes, immune suppressive cells, antigen presenting/processing machinery, metabolic alterations in the tumor microenvironment and oncogenic intracellular signaling. More recent and future scientific interests include the evaluation and clinical impact of tumor immune heterogeneity and editing.
If you are interested in becoming a member of the Schalper Lab, please see a list of available opportunities